Amsterdam Molecular Therapeutics Licenses Rights to IL-10

By Business Review Editor

Pharma Deals Review: Vol 2002 Issue 28 (Table of Contents)

Published: 2 Sep-2002

DOI: 10.3833/pdr.v2002.i28.1006     ISSN: 1756-7874

Section: Licensing



Amsterdam Molecular Therapeutics (AMT) licensed the use of interleukin-10 (IL-10) under Schering-Plough’s extensive IL-10 patent portfolio for ex vivo gene therapy for gastrointestinal inflammatory diseases...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details